comparemela.com

Latest Breaking News On - Zsuzsa beke - Page 1 : comparemela.com

Richter Gedeon Vegyeszeti Gyár Nyilvánosan Muködo Rt : Extraordinary Information

Richter has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals in Belgium Budapest, 3.

United statesZsuzsa bekeMithra pharmaceuticalsGedeon richter plcMithra pharmaceuticals saCentral eastern europeWestern europeLatin americaCentral nervous system

Richter Gedeon Vegyeszeti Gyár Nyilvánosan Muködo Rt : Extraordinary Information

Richter will commercialise Grünenthal s WHC product portfolio in Brazil Budapest, Hungary - 23 May 2023 - Gedeon Richter Plc. today. | May 23, 2023

United statesErik bogschBrasil farmaceutica ltdaCarlos simZsuzsa bekeGedeon richter plcGedeon richterBrasil importadora exportadoraRichter brazilLatin americaCentral eastern europeWestern europeCentral nervous systemPress releaseIchter richter hu0000123096

Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar referencing Prolia® and Xgeva®

/PRNewswire/ Gedeon Richter Plc. ("Richter") and Hikma Pharmaceuticals PLC ("Hikma") today announced that they have entered into an exclusive license.

United statesCity ofUnited kingdomSteve weissSusan ringdalSiggi olafssonDavid belianZsuzsa bekeUs communicationsPublic affairsDrug administrationGlobal affairsHikma pharmaceuticalsGedeon richter plcGedeon richterChief executive officer

Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar referencing Prolia® and Xgeva®

/PRNewswire/ Gedeon Richter Plc. ("Richter") and Hikma Pharmaceuticals PLC ("Hikma") today announced that they have entered into an exclusive license.

United arab emiratesUnited statesUnited kingdomCity ofSteve weissSusan ringdalSiggi olafssonDavid belianFitch hikmaZsuzsa bekeUs communicationsPublic affairsDrug administrationHikma pharmaceuticalsGedeon richter plcGlobal affairs

vimarsana © 2020. All Rights Reserved.